JBF Capital, Inc.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1483864 Aspen, CO

Position in REGN

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,117,700

-$745,500 QoQ

Shares Held

5,000

0.0% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.87%

of 13F equity value

Holder Rank

#455

of 1,329 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JBF Capital, Inc. holds $4,237,552 across 5 Biotechnology names. REGN ranks #1 (73.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	5,000	$3,117,700
2	COYA	Coya Therapeutics, Inc.	100,006	$585,035
3	ABUS	Arbutus Biopharma Corp	80,281	$385,348
4	PRTA	Prothena Corp Public Ltd Co	10,285	$100,690
5	LSTA	Lisata Therapeutics, Inc.	14,347	$48,779

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,117,700	5,000	0.0%	Shares	Sole	2026-08-13
2026-03-31	$3,863,200	5,000	0.0%	Shares	Sole	2026-05-08
2025-12-31	$3,859,350	5,000	—	Shares	Sole	2026-02-12
No filing history on record for this holder in this stock.